EUVIMEDEUVIMED entdecken
Crossref

Dysfunction of the Purinergic System in Bipolar Disorder

Magda Malewska-Kasprzak, Agnieszka Permoda, Janusz K Rybakowski

Neuropsychobiology · 2022 · 81 (4) · 265-270

DOI: 10.1159/000520146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychobiology, online erschienen am 11.03.2022. Verfasst von Magda Malewska-Kasprzak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Bipolar Disorder. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To verify the purinergic hypothesis of bipolar disorder (BD), we assessed the concentration of various components of the purinergic system in manic and depressed bipolar patients.

Methods

Sixty-two patients (19 male and 43 female), aged 22–69 (49 ± 14) years, with BD were studied. Twenty-three patients (9 male and 14 female) were assessed during a manic episode and subsequent remission, and 39 patients (10 male and 29 female) were investigated in a depressive episode and the following remission. Twenty-two healthy subjects (8 male and 14 female), aged 19–70 (41 ± 14) years, served as the control group (CG). The severity of symptoms was evaluated using the Hamilton Depression Rating Scale (HDRS) and the Young Mania Rating Scale (YMRS). The concentrations of uric acid (UA) were estimated by the uricase-based method, whereas xanthine dehydrogenase (XDH), adenosine (Ado), and adenosine deaminase (ADA) by ELISA.

Results

The mean score in the acute episode was 32 ± 8 points in the YMRS for mania and 31 ± 8 in the HDRS for depression. UA levels were significantly higher in female bipolar patients compared to the females in the CG. The concentrations of XDH, Ado, and ADA were significantly lower in bipolar patients both during an acute episode and remission compared to CG.

Conclusions

A significant dysfunction of the purinergic system in patients with BD was observed. In most instances, the disturbances were not different in the acute episode than in remission what qualifies them as trait dependent. The results may confirm the role of the purinergic system in the pathogenesis of BD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderFemaleHumansMaleManiaUric Acid

Stichwörter der Autor:innen

AdenosineAdenosine deaminaseBipolar disorderPurinergic systemUric acidXanthine dehydrogenase

Substanzen

Uric Acid

Autor:innen und Institutionen

  • Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznań, Poland.

Zitieren

APA

Malewska-Kasprzak, M., Permoda, A., & Rybakowski, J. K. (2022). Dysfunction of the Purinergic System in Bipolar Disorder. Neuropsychobiology, 81(4), 265-270. https://doi.org/10.1159/000520146

Vancouver

Malewska-Kasprzak M, Permoda A, Rybakowski JK. Dysfunction of the Purinergic System in Bipolar Disorder. Neuropsychobiology. 2022;81(4):265-270. doi:10.1159/000520146

BibTeX
@article{MalewskaKasprzak2022,
  author = {Malewska-Kasprzak, Magda and Permoda, Agnieszka and Rybakowski, Janusz K},
  title = {Dysfunction of the Purinergic System in Bipolar Disorder},
  journal = {Neuropsychobiology},
  year = {2022},
  volume = {81},
  number = {4},
  pages = {265--270},
  doi = {10.1159/000520146}
}
Kostenlos starten →